Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
Public ClinicalTrials.gov record NCT03028350. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this phase 2 study is to assess the safety and efficacy of oral ifetroban for the treatment of aspirin-exacerbated respiratory disease (AERD). AERD is a disease that involves asthma, recurring nasal polyps, and respiratory reactions to aspirin and other nonsteroidal anti-inflammatory drugs.
Study identification
- NCT ID
- NCT03028350
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2017 (Actual)
- Primary completion
- Apr 25, 2023 (Actual)
- Completion
- Apr 25, 2023 (Actual)
- Last update posted
- Jul 10, 2024
2017 – 2023
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University of Arizona Medical Center, Asthma & Airway Disease Research Center | Tucson | Arizona | 85724 | — |
| Antelope Valley Clinical Trials | Lancaster | California | 93534 | — |
| Scripps Clinic - Carmel Valley | San Diego | California | 92130 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| The Research Center | Hialeah | Florida | 33013 | — |
| Emory University School of Medicine, Sinus, Nasal, and Allergy Center | Atlanta | Georgia | 30308 | — |
| Deaconess Clinic | Evansville | Indiana | 47713 | — |
| Kansas City Allergy and Asthma Associates, PA | Overland Park | Kansas | 66210 | — |
| Advanced ENT & Allergy | Louisville | Kentucky | 40207 | — |
| Rochester Regional Health | Rochester | New York | 14607 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390-9035 | — |
| University of Virginia Medical Center | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03028350, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2024 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03028350 live on ClinicalTrials.gov.